KalVista Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2015 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Return On Equity for the quarter ending July 31, 2024 was -97.4 %, a 60.8% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2023 was -77.5 %, a 80.3% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2022 was -43 %, a 40.6% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2021 was -72.4 %, a 46% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -97.4 -36.8 -60.8% May 1, 2024 Jul 31, 2024
Q1 2024 -92.3 -35.4 -62.4% Feb 1, 2024 Apr 30, 2024
Q4 2023 -86.1 -32.5 -60.8% Nov 1, 2023 Jan 31, 2024
Q3 2023 -67.1 -14.7 -28.1% Aug 1, 2023 Oct 31, 2023
Q2 2023 -60.6 -15.1 -33.2% May 1, 2023 Jul 31, 2023
Q1 2023 -56.8 -18.8 -49.3% Feb 1, 2023 Apr 30, 2023
Q4 2022 -53.5 -22.3 -71.4% Nov 1, 2022 Jan 31, 2023
Q3 2022 -52.4 -21.5 -69.8% Aug 1, 2022 Oct 31, 2022
Q2 2022 -45.5 -12.5 -37.9% May 1, 2022 Jul 31, 2022
Q1 2022 -38.1 +2.56 +6.3% Feb 1, 2022 Apr 30, 2022
Q4 2021 -31.2 +22.5 +41.9% Nov 1, 2021 Jan 31, 2022
Q3 2021 -30.9 +16.6 +35% Aug 1, 2021 Oct 31, 2021
Q2 2021 -33 +4.73 +12.5% May 1, 2021 Jul 31, 2021
Q1 2021 -40.6 -9.43 -30.2% Feb 1, 2021 Apr 30, 2021
Q4 2020 -53.8 -21.6 -67.1% Nov 1, 2020 Jan 31, 2021
Q3 2020 -47.5 -21.8 -84.6% Aug 1, 2020 Oct 31, 2020
Q2 2020 -37.7 -15.1 -67% May 1, 2020 Jul 31, 2020
Q1 2020 -31.2 -6.28 -25.2% Feb 1, 2020 Apr 30, 2020
Q4 2019 -32.2 -12.6 -64.3% Nov 1, 2019 Jan 31, 2020
Q3 2019 -25.7 +4.41 +14.7% Aug 1, 2019 Oct 31, 2019
Q2 2019 -22.6 +33.7 +59.8% May 1, 2019 Jul 31, 2019
Q1 2019 -24.9 +30.7 +55.2% Feb 1, 2019 Apr 30, 2019
Q4 2018 -19.6 +46.2 +70.2% Nov 1, 2018 Jan 31, 2019
Q3 2018 -30.1 +40.1 +57.1% Aug 1, 2018 Oct 31, 2018
Q2 2018 -56.2 +4.18 +6.92% May 1, 2018 Jul 31, 2018
Q1 2018 -55.6 +7.77 +12.3% Feb 1, 2018 Apr 30, 2018
Q4 2017 -65.8 -0.88 -1.36% Nov 1, 2017 Jan 31, 2018
Q3 2017 -70.2 -16 -29.5% Aug 1, 2017 Oct 31, 2017
Q2 2017 -60.4 -6.64 -12.3% May 1, 2017 Jul 31, 2017
Q1 2017 -63.4 -12.5 -24.5% Feb 1, 2017 Apr 30, 2017
Q4 2016 -64.9 +22.1 +25.4% Nov 1, 2016 Jan 31, 2017
Q3 2016 -54.2 +406 +88.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -53.8 Apr 1, 2016 Jun 30, 2016
Q1 2016 -50.9 Jan 1, 2016 Mar 31, 2016
Q4 2015 -87 Oct 1, 2015 Dec 31, 2015
Q3 2015 -460 Jul 1, 2015 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.